Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Inflammation

Mesoblast Phase 3 Data Reveals a Single Injection of Rexlemestrocel-L Results in 2+ Years Pain Reduction, Opioid Sparing in Patients with Chronic Low Back Pain Due to Degenerative Disc Disease

Mesoblast announced results from a Phase 3 trial of its allogeneic mesenchymal precursor cell (MPC) therapy rexlemestrocel-L in patients with […]

Mesoblast Phase 3 Data Reveals a Single Injection of Rexlemestrocel-L Results in 2+ Years Pain Reduction, Opioid Sparing in Patients with Chronic Low Back Pain Due to Degenerative Disc Disease
3 weeks ago
Share

Reistone Biopharma Announces Positive Data from Phase 2 Trial of SHR0302 for Moderate to Severe Ulcerative Colitis

Reistone Biopharma announced positive results from the phase 2 AMBER2 trial evaluating SHR0302, in patients with moderate to severe ulcerative […]

Reistone Biopharma Announces Positive Data from Phase 2 Trial of SHR0302 for Moderate to Severe Ulcerative Colitis
4 weeks ago
Share

Aclaris Therapeutics Announces Positive Top Line Data from Phase 2 Trial of ATI-450 for Treating Moderate to Severe Rheumatoid Arthritis

Aclaris Therapeutics announced positive preliminary topline results from a phase 2 trial evaluating ATI-450, an investigational oral MK2 inhibitor, in […]

Aclaris Therapeutics Announces Positive Top Line Data from Phase 2 Trial of ATI-450 for Treating Moderate to Severe Rheumatoid Arthritis
1 month ago
Share

Some COVID-19 Patients Struggle with Forms of Psychosis as UCSF Psychiatrist Considers Potential Causes

Dr. Vivek Datta, a neuropsychiatrist with University of California, San Francisco, recently shared on local media in The City that […]

Some COVID-19 Patients Struggle with Forms of Psychosis as UCSF Psychiatrist Considers Potential Causes
2 months ago
Share

Top Neurology Investigators from Medical University South Carolina (MUSC) Drive Virtual Clinical Trial Investigating NeuroCOVID

In addition to the stages (incubation, symptomatic, early pulmonary & late pulmonary) associated with a SARS-CoV-2 infection, known as COVID-19, two […]

Top Neurology Investigators from Medical University South Carolina (MUSC) Drive Virtual Clincial Trial Investigating NeuroCOVID
4 months ago
Share

Revance’s DaxibotulinumtoxinA for Injection Does Not Meet Endpoints in Phase 2 Plantar Fasciitis Trial

Revance Therapeutics reported results from its Phase 2 clinical trial of DaxibotulinumtoxinA for Injection for the management of plantar fasciitis, […]

Revance’s DaxibotulinumtoxinA for Injection Does Not Meet Endpoints in Phase 2 Plantar Fasciitis Trial
4 months ago
Share

Amgen, AstraZeneca Report Phase 3 NAVIGATOR Trial of Tezepelumab Meets Primary Endpoint in Patients with Severe Asthma

Amgen and AstraZeneca  announced positive results from NAVIGATOR, a phase 3 trial evaluating tezepelumab versus placebo, both added to standard […]

Amgen, AstraZeneca Report Phase 3 NAVIGATOR Trial of Tezepelumab Meets Primary Endpoint in Patients with Severe Asthma
4 months ago
Share

Gilead and Galapagos Report Data from SELECTION Trial of Filgotinib in Moderate to Severe Ulcerative Colitis

Gilead and Galapagos  presented late-breaking data from the phase 2b/3 SELECTION trial at the 2020 United European Gastroenterology Week (UEGW) […]

Gilead and Galapagos Report Data from SELECTION Trial of Filgotinib in Moderate to Severe Ulcerative Colitis
5 months ago
Share

SOBI and Selecta Report Data from Phase 2 COMPARE Study of SEL-212 in Patients with Chronic Refractory Gout

Swedish Orphan Biovitrum and Selecta Biosciences reported topline data from the phase 2 COMPARE study, which evaluated the efficacy of […]

SOBI and Selecta Report Data from Phase 2 COMPARE Study of SEL-212 in Patients with Chronic Refractory Gout
5 months ago
Share

Abivax’s Phase 2a Clinical Trial Data Evidences ABX464 Effective Against Ulcerative Colitis

Abivax (Euronext Paris: FR0012333284 – ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory […]

Abivax’s Phase 2a Clinical Trial Data Evidences ABX464 Effective Against Ulcerative Colitis
6 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.